A 'Laser Phase Plate' Breakthrough Allows Scientists to See the Smallest Human Proteins

Inside every human cell, tens of thousands of different proteins act as the molecular machinery of life—ferrying cargo, repairing DNA, and triggering cellular division. Yet, despite decades of advancements in microscopy, scientists have been operating partially in the dark. It is estimated that more than 90 percent of the proteins found inside human cells are simply too small to be imaged clearly by existing technology. Without a clear picture of how these proteins are shaped and how they interact, designing drugs to target them when they malfunction remains a process of educated guesswork.[4]

That fundamental limitation is now poised to fall. In a coordinated release of papers across major scientific journals, researchers from the University of California, Berkeley, and the Chan Zuckerberg Biohub have announced the successful demonstration of a "laser phase plate." The device, integrated into a state-of-the-art cryo-electron microscope, uses an intensely focused laser to dramatically boost the contrast of the images it produces. After 15 years of being dismissed by many as theoretically elegant but practically impossible to build, the technology has produced its first high-resolution images of previously elusive biological structures.[1][2][3]

To understand the breakthrough, one must look at the current gold standard for structural biology: cryo-electron microscopy (cryo-EM). The technique, which won the Nobel Prize in Chemistry in 2017, involves flash-freezing protein samples in a thin layer of vitreous ice and firing a beam of electrons through them. Because electrons have a much shorter wavelength than visible light, they can resolve individual atoms. A detector captures the electrons that pass through, and software stitches thousands of these 2D "shadows" into a 3D model.[4][6]

The problem lies in the physics of contrast. Biological molecules are composed of light elements like carbon, nitrogen, and oxygen, which do not scatter electrons very strongly. When the electron beam passes through a small protein, the resulting image is incredibly faint—akin to looking for a clear glass bead submerged in a glass of water. To generate enough contrast to see anything at all, microscopists have traditionally had to throw the image slightly out of focus, a compromise that inherently destroys the highest-resolution details.[3][7]

The theoretical solution has been known for nearly a century: phase contrast. By shifting the phase of the unscattered electrons by exactly 90 degrees, they can be made to interfere with the scattered electrons, converting invisible phase differences into stark, high-contrast amplitude differences. While physical phase plates made of carbon have been tried in electron microscopes, they quickly accumulate static electric charge from the electron beam, degrading the image and rendering them useless for long data-collection runs.[2][6]

The Berkeley team, led by physicist Holger Müller, hypothesized that a laser could act as an invisible, indestructible phase plate. Because light consists of electromagnetic waves, an intense enough laser field can exert a "ponderomotive force" on passing electrons, slowing them down just enough to shift their phase without physically touching or scattering them. The engineering hurdle was the sheer amount of light required: the laser needed to be roughly 100 million times brighter than the surface of the sun, contained within the vacuum of an electron microscope.[2][3][4]

The evidence published in Science confirms that the team successfully built this optical cavity. Using a custom-modified Thermo Fisher Krios microscope dubbed "Theia," the researchers bounced a continuous-wave laser between two highly polished mirrors, building up a massive standing wave of light directly in the path of the electron beam. The results provide strong evidence that the mechanism works exactly as predicted by quantum mechanics, delivering a stable, tunable 90-degree phase shift with no electrostatic charging.[2][6]

To prove the system's biological utility, the Berkeley team imaged hemoglobin, the oxygen-carrying protein in red blood cells. At roughly 64 kilodaltons, hemoglobin sits at the absolute lower limit of what conventional cryo-EM can resolve. With the laser phase plate turned on, the contrast improved dramatically. In paired experiments, the resolution of the hemoglobin structure improved by up to 44 percent, allowing the software to build a much more accurate atomic model from the faint signals.[3][7]

Crucially, the evidence shows that the laser does not degrade high-resolution data. When the team imaged aldolase, a larger benchmark enzyme that is relatively easy to capture with standard cryo-EM, the laser phase plate still improved the resolution. This confirms that the technology is strictly additive, boosting the low-frequency contrast (the overall shape and visibility of the molecule) without blurring the high-frequency details (the exact positions of individual atoms).[2][7]

While the single-laser system proved the concept, a parallel effort by the CZ Biohub team has already pushed the engineering further. In a preprint posted to bioRxiv, the Biohub researchers detailed a second-generation "crossed laser phase plate" (xLPP). This design uses two orthogonal laser beams arranged in an X-shape. The dual-beam approach splits the required optical power between two cavities, lowering the stress on the mirrors and reducing the risk of catastrophic thermal failure.[4][5][7]

The xLPP design also solves a subtle optical artifact. A single laser beam creates a slight asymmetry in the phase shift, which can produce faint "ghost images" that overlap with the real protein structure. The crossed lasers cancel out this asymmetry. Using the xLPP, the Biohub team achieved a staggering 1.79 Ångström resolution on apoferritin, a standard calibration protein. This near-atomic resolution proves that the dual-laser system can match the stringent quality standards required by modern structural biology.[5][7]

The most profound impact of the laser phase plate, however, will likely not be in imaging isolated proteins, but in a rapidly emerging field called cryo-electron tomography (cryo-ET). Instead of purifying proteins and studying them in a vacuum, cryo-ET aims to image intact, flash-frozen cells. By tilting the cellular sample and taking pictures from multiple angles, scientists can reconstruct a 3D volume of the cell, revealing how different proteins interact with each other in their native, crowded environment.[1][4]

Because intact cells are much thicker than isolated proteins, the electron beam scatters heavily, resulting in an incredibly noisy image where individual proteins are nearly impossible to spot. The Biohub team's preprint provides early evidence that the laser phase plate can cut through this noise. When imaging thick E. coli cells (roughly 350 nanometers deep), the xLPP provided a massive contrast boost, making internal cellular structures pop out clearly against the background.[5][7]

Despite the clear success of the prototypes, there is transparent uncertainty regarding how quickly this technology will reach the broader scientific community. The current systems are highly bespoke, requiring custom-machined microscope columns and constant tuning by expert optical physicists. As Holger Müller noted regarding the Berkeley prototype, "Ours is not street legal." The optical cavities require extreme precision; if the mirrors drift by even a fraction of a nanometer, the phase shift is lost.[6][7]

The next major hurdle is commercialization. Researchers are currently collaborating with microscope manufacturers like Thermo Fisher Scientific to determine if the laser phase plate can be miniaturized and stabilized into a plug-and-play module. Until it can be mass-produced and operated by standard facility technicians rather than dedicated physicists, its impact will be confined to a few elite imaging centers.[6]

If those engineering challenges are met, the laser phase plate represents a generational leap for biology. By illuminating the 90 percent of the proteome that has remained hidden, and by allowing scientists to watch those proteins operate inside the living machinery of the cell, the technology provides a new foundational map for human health. As Biohub's imaging director Bridget Carragher summarized, "It's like seeing first light through a telescope. The science it enables—that comes next."[4][7]